APA (7th ed.) Citation

Xu, Y., Wang, L., Zimmerman, M. D., Chen, K., Huang, L., Fu, D., . . . Shen, X. (2018). Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. PLoS Pathogens, 14(4), 1. https://doi.org/10.1371/journal.ppat.1006974

Chicago Style (17th ed.) Citation

Xu, Yitian, et al. "Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis." PLoS Pathogens 14, no. 4 (2018): 1. https://doi.org/10.1371/journal.ppat.1006974.

MLA (9th ed.) Citation

Xu, Yitian, et al. "Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis." PLoS Pathogens, vol. 14, no. 4, 2018, p. 1, https://doi.org/10.1371/journal.ppat.1006974.